Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$105,000.00

Targeting connexins to promote functional spinal cord repair

FY 2011-12

Summary
Spinal cord injury (SCI) has the potential to cause transformative life changes to people of all ages. The consequences of these injuries vary depending on the severity and can include paralysis and loss of the ability to properly regulate various bodily functions. At the root of many spinal cord injuries is an initial trauma that results in an inflammatory response and death of cells surrounding the site of lesion. Commonly, what follows is an imbalance in the regulation of myelin, the lipid-rich membrane covering of nerve axons produced by oligodendrocytes in the central nervous system. Recent work has implicated gap junction proteins in contributing to myelin breakdown and secondary neuronal injury. Gap junctions are composed of a series of channels that permit the passage of small molecules. Each of these channels is composed of two hemichannels, or connexons, which are each made up of six connexin proteins expressed by adjacent cells. In the nervous system alone, ten connexins are expressed preferentially by neurons, glia, and their progenitors. We hypothesize that connexins play a role in demyelination, subsequent oligodendrocyte differentiation and remyelination after SCI, and also contribute to the evolution of secondary tissue damage after SCI. To study this, we propose the following specific objectives: - Screen natural compound libraries to identify compounds that modulate expression and/or function of connexins of interest - Utilize slow release biomaterial delivery systems to deliver lead compounds to the spinal cord in vivo. - Pre-clinical testing of bioactive lead compounds to prevent myelin breakdown and demyelination as well as stimulate remyelination in animal models of SCI. Currently, there exists no effective treatment for disabilities characterized by demyelination. As such, this project seeks to contribute important knowledge to the field that will potentially help countless individuals suffering from these conditions.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
257414
Name
Cooke Donald M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Targeting connexins to promote functional spinal cord repair
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Biochemistry; Connexins; Gap Junctions; Neuroregeneration; Spinal Cord Repair
Abstract
Spinal cord injury (SCI) has the potential to cause transformative life changes to people of all ages. The consequences of these injuries vary depending on the severity and can include paralysis and loss of the ability to properly regulate various bodily functions. At the root of many spinal cord injuries is an initial trauma that results in an inflammatory response and death of cells surrounding the site of lesion. Commonly, what follows is an imbalance in the regulation of myelin, the lipid-rich membrane covering of nerve axons produced by oligodendrocytes in the central nervous system. Recent work has implicated gap junction proteins in contributing to myelin breakdown and secondary neuronal injury. Gap junctions are composed of a series of channels that permit the passage of small molecules. Each of these channels is composed of two hemichannels, or connexons, which are each made up of six connexin proteins expressed by adjacent cells. In the nervous system alone, ten connexins are expressed preferentially by neurons, glia, and their progenitors. We hypothesize that connexins play a role in demyelination, subsequent oligodendrocyte differentiation and remyelination after SCI, and also contribute to the evolution of secondary tissue damage after SCI. To study this, we propose the following specific objectives: - Screen natural compound libraries to identify compounds that modulate expression and/or function of connexins of interest - Utilize slow release biomaterial delivery systems to deliver lead compounds to the spinal cord in vivo. - Pre-clinical testing of bioactive lead compounds to prevent myelin breakdown and demyelination as well as stimulate remyelination in animal models of SCI. Currently, there exists no effective treatment for disabilities characterized by demyelination. As such, this project seeks to contribute important knowledge to the field that will potentially help countless individuals suffering from these conditions.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cooke, Donald M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~